Photo taken from Cristina Ortega Duran/LinkedIn
Sep 10, 2024, 01:21
Cristina Ortega Duran: Evinnova clinical trial platform and how it supports oncology for toxicity monitoring in a novel patient-centric way
Cristina Ortega Duran, President/CEO of Evinova, shared on LinkedIn:
“I grew up in Madrid but Barcelona has unique elements that make it extra special… the beautiful seaside, the Sagrada Familia, and of course ESMO – European Society for Medical Oncology!
I am so excited to be there and see many of you face to face. My diary is filling up quickly, with interest in our Evinnova clinical trial platform and how it supports oncology for toxicity monitoring in a novel patient-centric way, examples CRS, ILD, Stomatitis, GI, Ocular, etc.
Please reach out, if you would like to meet up and get a demo together, or a glass of vino. E …vino…va a ESMO – European Society for Medical Oncology.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 09:39
Nov 13, 2024, 08:59